COMPARED TO INSULIN GLARGINE, TIRZEPATIDE REDUCES THE PREVALENCE OF THE METABOLIC SYNDROME IN PATIENTS WITH TYPE 2 DIABETES AND HIGH CARDIOVASCULAR RISK: POST-HOC ANALYSIS OF SURPASS-4
| Autor: | Nicholls, S., D'Alessio, D., Wiese, R., Pavo, I., Zeytinoglu, M., Romera, I., Weerakkody, G., Longuet, C. |
|---|---|
| Zdroj: | In Canadian Journal of Diabetes November 2023 47(7) Supplement:S150-S151 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect